Towards Healthcare
Pain Management Drugs Market to Reach USD 126.17 Bn by 2034

Pain Management Drugs Market 2025 Rising OTC Demand

According to market projections, the pain management drugs sector is expected to grow from USD 84.1 billion in 2024 to USD 126.17 billion by 2034, reflecting a CAGR of 4.14%. The rising prevalence of chronic pain and growing research and development activities drive the global market. North America dominated the market due to the availability of state-of-the-art research and development facilities and the presence of key players.

Content

  • Insight Code: 6212
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The pain management drugs market in 2025 is valued at USD 87.58 billion and is projected to climb to USD 126.17 billion by 2034, with a CAGR of 4.14% over the forecast period.

North America is leading the pain management drugs market due to the availability of state-of-the-art research and development facilities, favorable government support, and the presence of key players.

The pain management drugs market includes six segments by drug class, by indication, by route of administration, by distribution channel, by end-user, and by region.

Key trends include the rising prevalence of acute and chronic pain disorders, the rise of OTC medications, and technological advancements.

Food and Drug Administration, National Initiative for the Care of the Elderly, Press Information Bureau
Any Questions